Identification of a DNA variant associated with adult type hypolactasia

Details for Australian Patent Application No. 2002355471 (hide)

Owner National Public Health Institute

Inventors Savilahti, Erkki; Enattah, Nabil; Jarvela, Irma; Terwilliger, Joseph; Peltonen, Leena; Sahi, Timo

Agent Shelston IP

Pub. Number AU-B-2002355471

PCT Number PCT/EP02/08963

PCT Pub. Number WO2003/014342

Priority 01119528.6 14.08.01 EP; 60/315,955 31.08.01 US; 01119377.8 10.08.01 EP

Filing date 9 August 2002

Wipo publication date 24 February 2003

Acceptance publication date 13 September 2007

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 9/24 (2006.01) Enzymes, e.g. ligases (6.) - acting on glycosyl compounds (3.2)

C12N 9/38 (2006.01) Enzymes, e.g. ligases (6.) - acting on beta-galactose-glycoside bonds, e.g. beta-galactosidase

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/34 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 01119528.6 14.08.01 EP; 60/315,955 31.08.01 US; 01119377.8 10.08.01 EP

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002355471

13 September 2007 Application Accepted

  Published as AU-B-2002355471

17 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002355472-METHOD AND DEVICE FOR IDENTIFYING DEVICES CONNECTED TO A COMMUNICATION NETWORK

2002355470-POLYMORPHISMS IN THE HUMAN GENE FOR CYP1A2 AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS